Meeting
2020 Genitourinary Cancers Symposium
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma (S/R RCC) to reveal potential determinants of poor prognosis and response to immune checkpoint inhibitors (ICI).
Authors
Ziad Bakouny
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA
Ziad Bakouny , David A. Braun , Sachet A. Shukla , Wenting Pan , Xin Gao , Yue Hou , Abdallah Flaifel , Amin Nassar , Sarah Abou Alaiwi , Ronan Flippot , John A. Steinharter , Pier Vitale Nuzzo , Yuko Ishii , Petra Ross-Macdonald , Gwo-Shu Mary Lee , David F. McDermott , Daniel Yick Chin Heng , Sabina Signoretti , Eliezer Mendel Van Allen , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 715)
Abstract #
715
Poster Bd #
H13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
ARID1A deficiency in triple-negative breast cancer induces adaptive immune resistance and sensitivity to immune checkpoint inhibitors.
First Author: Margaret Chen
Poster
2020 ASCO Virtual Scientific Program
Genomic landscape and immune phenotype of malignant pleural mesothelioma.
First Author: Meera Patel
Poster
2022 ASCO Annual Meeting
Assessment of a 4-chemokine signature in prediction of T-cell inflammation and response to immune checkpoint inhibition across tumor types.
First Author: Joan Miguel Romero
Poster
2024 ASCO Genitourinary Cancers Symposium
Preclinical testing of a novel PD-L1 inhibitor for the treatment of renal cell carcinoma.
First Author: Michelle Hsu